<?xml version="1.0" encoding="UTF-8"?>
<ref id="B65-molecules-25-02944">
 <label>65.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mastaglio</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Ruggeri</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Risitano</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Angelillo</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Yancopoulou</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Mastellos</surname>
    <given-names>D.C.</given-names>
   </name>
   <name>
    <surname>Huber-Lang</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Piemontese</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Assanelli</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Garlanda</surname>
    <given-names>C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The first case of COVID-19 treated with the complement C3 inhibitor AMY-101</article-title>
  <source>Clin. Immunol.</source>
  <year>2020</year>
  <volume>215</volume>
  <fpage>108450</fpage>
  <pub-id pub-id-type="doi">10.1016/j.clim.2020.108450</pub-id>
  <?supplied-pmid 32360516?>
  <pub-id pub-id-type="pmid">32360516</pub-id>
 </element-citation>
</ref>
